These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32010152)

  • 1. Immunomodulatory Protective Effects of Rb9 Cyclic-Peptide in a Metastatic Melanoma Setting and the Involvement of Dendritic Cells.
    Machado FC; Girola N; Maia VSC; Bergami-Santos PC; Morais AS; Azevedo RA; Figueiredo CR; Barbuto JAM; Travassos LR
    Front Immunol; 2019; 10():3122. PubMed ID: 32010152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ig V
    Girola N; Matsuo AL; Figueiredo CR; Massaoka MH; Farias CF; Arruda DC; Azevedo RA; Monteiro HP; Resende-Lara PT; Cunha RL; Polonelli L; Travassos LR
    Peptides; 2016 Nov; 85():1-15. PubMed ID: 27575453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma.
    Figueiredo CR; Azevedo RA; Mousdell S; Resende-Lara PT; Ireland L; Santos A; Girola N; Cunha RLOR; Schmid MC; Polonelli L; Travassos LR; Mielgo A
    Front Immunol; 2018; 9():1132. PubMed ID: 29875777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation.
    Jin GH; Hirano T; Murakami M
    Int Immunol; 2008 Jun; 20(6):783-9. PubMed ID: 18448458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
    Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
    J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INAM plays a critical role in IFN-γ production by NK cells interacting with polyinosinic-polycytidylic acid-stimulated accessory cells.
    Kasamatsu J; Azuma M; Oshiumi H; Morioka Y; Okabe M; Ebihara T; Matsumoto M; Seya T
    J Immunol; 2014 Nov; 193(10):5199-207. PubMed ID: 25320282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of melanoma growth after treatment with dendritic cells in a Tyr-SV40E murine model requires CD4+ T cells but not CD8+ T cells.
    Milling SW; Sai T; Silvers WK; Mintz B
    Melanoma Res; 2004 Dec; 14(6):555-62. PubMed ID: 15577330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmacytoid dendritic cells play a key role in tumor progression in lipopolysaccharide-stimulated lung tumor-bearing mice.
    Rega A; Terlizzi M; Luciano A; Forte G; Crother TR; Arra C; Arditi M; Pinto A; Sorrentino R
    J Immunol; 2013 Mar; 190(5):2391-402. PubMed ID: 23355734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The helminth-derived peptide GK-1 induces an anti-tumoral CD8 T cell response associated with downregulation of the PD-1/PD-L1 pathway.
    Rodríguez-Rodríguez N; Madera-Salcedo IK; Bugarin-Estrada E; Sánchez-Miranda E; Torres-García D; Cervantes-Torres J; Fragoso G; Rosetti F; Crispín JC; Sciutto E
    Clin Immunol; 2020 Mar; 212():108240. PubMed ID: 31299381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response.
    Ji Q; Gondek D; Hurwitz AA
    J Immunol; 2005 Aug; 175(3):1456-63. PubMed ID: 16034082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.
    Markov OV; Mironova NL; Sennikov SV; Vlassov VV; Zenkova MA
    PLoS One; 2015; 10(9):e0136911. PubMed ID: 26325576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate and adoptive immune cells contribute to natural resistance to systemic metastasis of B16 melanoma.
    Umeshappa CS; Zhu Y; Bhanumathy KK; Omabe M; Chibbar R; Xiang J
    Cancer Biother Radiopharm; 2015 Mar; 30(2):72-8. PubMed ID: 25714591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
    Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
    J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10.
    de Melo FM; Braga CJ; Pereira FV; Maricato JT; Origassa CS; Souza MF; Melo AC; Silva P; Tomaz SL; Gimenes KP; Scutti JA; Juliano MA; Zamboni DS; Câmara NO; Travassos LR; Ferreira LC; Rodrigues EG
    Immunol Cell Biol; 2015 Jan; 93(1):86-98. PubMed ID: 25223833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2: coordination of dendritic and CD8+ cell responses.
    Murphy WJ; Welniak L; Back T; Hixon J; Subleski J; Seki N; Wigginton JM; Wilson SE; Blazar BR; Malyguine AM; Sayers TJ; Wiltrout RH
    J Immunol; 2003 Mar; 170(5):2727-33. PubMed ID: 12594303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated antigen/IL-21-transduced dendritic cell vaccines enhance immunity and inhibit immunosuppressive cells in metastatic melanoma.
    Aravindaram K; Wang PH; Yin SY; Yang NS
    Gene Ther; 2014 May; 21(5):457-67. PubMed ID: 24572790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.
    Asavaroengchai W; Kotera Y; Koike N; Pilon-Thomas S; Mulé JJ
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):524-33. PubMed ID: 15282530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor.
    Yaddanapudi K; Putty K; Rendon BE; Lamont GJ; Faughn JD; Satoskar A; Lasnik A; Eaton JW; Mitchell RA
    J Immunol; 2013 Mar; 190(6):2984-93. PubMed ID: 23390297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.